MANY lower vertebrates alter the color of their skin in response to variations in background coloration. Background adaptation is of paramount importance to these animals for survival. The reg ulation of background adaptation represents an attractive model for the analysis of the interactions between peptidergic neuroen docrine factors. In most species a-melanocyte-stimulating hor mone (a-MSH), dominates the hormonal control of pigment mi gration in response to changes in background coloration. a-MSH is produced in the melanotropes of the pars intermedia of most vertebrates, and induces pigment dispersion ( 1) . In teleosts a neu rohormone, melanin-concentrating hormone (MCH), antagonizes a-MSH in this respect (5) . As in other teleosts (4) , in tilapia (Oreochromis mossambicus) MCH is synthesized in the hypo thalamus and transported to the pituitary pars nervosa (18) . Also in higher vertebrates, MCH is produced in the hypothalamus (4) , and it plays a role in the stress response, in osmoregulation, and in lactation (2) . In teleosts the MCH system appeared to be re sponsive to stress and ionic challenges as well (4, 6, (15) (16) (17) , in addition to its function in the regulation of skin color.
There are indications that MCH may affect background adaptation at the level of the pituitary by inhibiting a-MSH re lease from the pars intermedia. Firstly, MCH nerve terminals are located in the vicinity of pars intermedia cells (10, 29) . Further more, it has been reported that trout injected with MCH had decreased plasma a-MSH levels (7) , and immunoabsorbance of endogenous MCH in trout and eel pituitary tissue enhanced the release of a-MSH in vitro (9) .
At present, little is known on the sensitivity of pituitary me lanotropes to MCH, and on species differences for the effect of MCH on melanotropes. In the teleost skin, MCH induces aggre gation of melanin at concentrations that occur in the blood (3, 4) , whereas administration of high concentrations of MCH to melanophores induces pigment dispersion. The latter has been ex plained by binding of MCH to a-MSH receptors on the melanophores (12, 19) . The MCH concentration-response curve of MCH on auditory gating in rats is also biphasic (27) . This raises the question whether the concentration-response relationship of MCH on a-MSH release is biphasic as well.
Three forms of a-MSH are known: des-, mono-, and diacetylated a-MSH. In tilapia, all three a-MSH forms are released from the neurointermediate lobe (NIL) (25) . Acetylation of a-MSH is of functional significance, because the isoforms of a-MSH have dif ferent melanotropic and corticotropic potencies in fish (22, 24) . Monoacetylated and diacetylated a-MSH are most effective on pig ment dispersion in trout (22) , whereas in particular diacetylated a-MSH has corticotropic activity in tilapia (8, 24) .
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The purpose of the present study was to gain more insight into the action of MCH at the pituitary level. We therefore quan titatively and qualitatively analyzed the effects of MCH and MCH(2-17), a MCH analogue lacking the AMerminal amino acid, which was helpful in elucidating the mechanisms of action of MCH on the teleost skin (11, 26) , on the release of a-MSH in vitro from the tilapia pituitary gland.
METHOD

Animals
Male and female tilapia (Oreochromis mossambicus), average weight 80 g, were bred in the aquarium facility of the Dept, of Animal Physiology of the University of Nijmegen. They were kept in fresh water at 28°C and were fed a commercial dried fish food (Tetramin). The fish were kept in glass aquaria, illuminated by overhead TL tubes, with a day-night rhythm of 12 h light and 12 h darkness. Immediately after removal from the tank, the animals were sacrificed by spinal transection and pituitary glands were dissected from the brain.
Superfusion o f Neurointermediate Lobe Tissue
One or two freshly dissected pituitaries or NILs were placed on a nylon gauze in a 10-//1 superfusion chamber. A multichannel peristaltic pump (Whatson Marlow) was used to pump carbogenaerated incubation medium (IM) {142 mM NaCl, 2 mM KC1, 2 mM CaCl2, 15 mM HEPES (pH 7.38), 0.3 mg/ml bovine serum albumin (Sigma), 2.5 mg/ml glucose] through each chamber at a rate of 30 /d/min. The superfusion chambers as well as the IM were thermostat controlled at 28°C. The effluent from each cham ber was collected in fractions over varying periods with an Isco (Retriever II model) fraction collector. During at least 3 h super fusion fractions were collected before switching to pulse medium containing MCH or MCH(2-17) (both synthesized by Dr. T.O. Matsunaga at the lab of Dr. V. J. Hruby and kindly provided by Dr. M. E. Hadley, Tuscon, AZ) (32), for a 25-30-min period. After the pulse the superfusion was continued with IM. The col lected fractions were stored immediately at -20°C until a-MSH radioimmunoassay.
Immunoneutralization o f MCH From Tilapia NILs
NILs from tilapia kept in dark glass aquaria were dissected and individually preincubated in 100 /¿I IM, containing 5 mg/ml (w/v) glucose, during 1 h at 28°C. Subsequently, the NILs were transferred into 30 //I IM containing either 0.1% (v/v) MCH an tiserum (a kind gift of Dr. B.I. Baker and Dr. H. Kawauchi) (28) or 0.1% (v/v) normal rabbit serum. The vials were aerated with carbogen, sealed, and shaken gently at 28°C for a 15-h incubation period. After this static incubation, media were collected and stored at -20°C until a-MSH radioimmunoassay; subsequently, the NILs were superfused as described above.
Reversed-Phase HPLC Analysis
To determine the effect of MCH on the profile of the secretory signal, superfusate was submitted to HPLC analysis. Different forms of a-MSH were separated on a Spherisorb 10 ODS column (Bisschof) as described previously (25) . In short, the primary solvent was buffer B (0.5 M formic acid, 0.14 M pyridine, pH 3.0) and elution was accomplished with a gradient of 1-propanol at a flow rate of 2 ml/min. Fractions of 0.6 ml were collected. The fractions were dried in a Speedvac concentrator (Savant), diluted into 0.05 N HC1, 50% methanol, and submitted to a-MSH radioimmunoassay.
a-MSH Radioimmunoassay
The a-MSH radioimmunoassay (RIA) with L9 a-MSH anti serum has been described previously (24) . The antiserum is equally sensitive to des-, mono-and diacetyl a-MSH. Cross-reac tivity of the a-MSH antiserum with MCH [preliminary results have been reported by De Koning et al. (13)] and MCH (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) was assessed (see the Results section).
Processing of Data and Statistics
The suits section) we calculated that 10 pM MCH in a 75 p\ RIA sample is equivalent to 40 pg immunoreactive a-MSH. This value was subtracted from the RIA data of pulse fractions. EC50 was estimated as described previously (23) . Results are presented as means + , -, or ± SEM. For statistical analysis data were log transformed where appropriate. For the concentration-response relationships statistical analyses were performed using the paired Student's Mest. For each concentration, the maximum value dur ing the pulse of each incubation was tested against its own control value of basal release. In other cases the unpaired Student's ttest was used. To test parallelism of dilution curves the computer program PHARM/PCS-version 4.1 (30) was used.
R E S U L T S Quantitative Effects of MCH on a-MSH Release
At concentrations below 1 f.iM, MCH caused a concentrationdependent inhibition of a-MSH release during in vitro superfu sion of tilapia NILs [ Fig. 1(A,C) ], and at 10 pM a-MSH release was stimulated [ Fig. 1(B) ]. The effect of MCH on the a-MSH release lasted for the duration of the pulse; after the pulse a-MSH release did restore to basal levels. The MCH concentration in ducing 50% of maximum inhibition of a-MSH release (EC50), using the data points up to and including 250 nM, was estimated to be 19 nM with a maximum inhibition of 42%. At 10 pM MCH the a-MSH release was stimulated with a maximum stimulation of 96 ± 17% (p < 0.001) [ Fig. 1(C) ]. Taking into account the slight cross-reactivity of MCH with the a-MSH antiserum (0.0032%) (Fig. 2) , this percentage decreased marginally to 87 ± 22% (p < 0.001 compared with basal release). However, be cause the dilution curve for MCH only approximately paralleled the a-MSH dilution curve in the a-MSH radioimmunoassay ( Fig.  2 ; the slope of log transformed curves was significantly different, p < 0.01) an additional control was performed. To mimic pulse conditions, MCH was added to prepulse superfusates to a final concentration of 10 pM. This yielded a nonsignificant increase (p = 0.88) of immunoreactive a-MSH of 2 ± 10 pg (and 16 ± 16%; n = 6) compared with untreated prepulse fractions. During the 10 pM MCH pulse the increase of immunoreactive a-MSH was 108 ± 33 pg (95 ± 28%; n = 5), which was significantly higher (p < 0.01) than the increase measured when MCH was added afterwards to superfusates. M CH (2-17), a MCH analogue that, in contrast to MCH, did not cross-react with the a-MSH antiserum (Fig. 2) , induced a significant stimulation of the a-MSH release at concentrations of 10 and 35 pM (Fig. 3) . The stimulation of a-MSH release by 10 pM MCH(2-17) was com parable with that evoked by 10 pM MCH.
Effect of Endogenous MCH on a-MSH Secretion
After incubation of tilapia NILs with 0.1% MCH antiserum, to immunoneutralize endogenous MCH, a-MSH release signifi cantly increased compared with NILs incubated in medium con taining normal rabbit serum [ Fig. 4(A) ]. After 15 h of static in cubation, the antiserum was washed out by superfusion of the NILs with fresh incubation medium. During this superfusion the a-MSH release of the NILs incubated with the MCH antiserum returned to control levels within 2 h [ Fig. 4(B) ].
Effects of MCH on the Release of a-MSH Isoforms
To study the qualitative effect of MCH on a-MSH release, the isoforms of a-MSH released before and during pulses with 100 and 250 nM MCH were analyzed by HPLC. Des-, mono-, and diacetylated a-MSH were released during MCH pulses as well as under control conditions (Fig. 5) . During the 100 and 250 nM MCH pulses the amount of monoacetylated a-MSH de creased relatively more than the amounts of des-and diacetylated a-MSH, when compared to control. Taking the area under the curve of diacetylated a-MSH (di), monoacetylated a-MSH (mono), and desacetylated a-MSH (des), we calculated di/mono and des/mono ratios of 0.45 and 0.38 for control, 0.73 and 0.50 during a 100 nM MCH pulse, and 0.95 and 0.61 during a 250 nM MCH pulse, respectively. The highest increase of the ratios was found at the concentration (250 nM) where the overall in hibitory effect was the strongest (Figs. 1 and 5 ). (12) and the biphasic concentration-response curve of the effect of MCH in auditory gating of rats (27) . Significant inhibition of a-MSH release from tilapia NILs oc curred from 10 to 250 nM MCH. In trout, MCH tested at a single dose of 100 nM did not inhibit a-MSH release in vitro (9) . The difference with tilapia could be due to other incubation condi tions or to species differences in sensitivity of teleost melanotropes to MCH. An attractive hypothesis is that in trout 100 nM MCH reflects the turning point in the concentration-response curve. Tilapia melanotropes appeared to be less sensitive to MCH than tilapia scale melanophores: the EC50 of the effect of MCH on a-MSH release was 19 nM (this study), whereas the EC50 on pigment migration was 1 nM (20) . We reason that the lower sensitivity of melanotropes to MCH reflects the mode of MCH targeting, which is neuroendocrine in the pituitary and in the classical sense endocrine for the skin. Pituitary melanotropes are in close contact with the MCH-containing neurons of the neu rohypophysis of tilapia (personal observation) and other teleosts (10, 29) , and MCH is endogenously released [(9), this study], whereas the effect of MCH on melanophores is exerted by rela tively low circulating MCH levels (14, 21) . The difference in sen sitivity of the tissues cannot be attributed to differences in the peptide sequences of synthetic salmon MCH and tilapia MCH, because we previously demonstrated that the sequences of both peptides are identical (18) . The sensitivity of tilapia melanotropes to MCH is comparable with the sensitivity to dopamine, another potent inhibitor of a-MSH release in tilapia [EC5", 10 nM \ Dr. A. E. Lamers personal communication; see also (25) ]. However, MCH modulates the secretory output of the melanotropes not only quantitatively but also qualitatively by selectively decreas ing the release of monoacetylated a-MSH. In this respect MCH differs from dopamine, which indiscriminately inhibited the re lease of mono-and diacetylated a-MSH from tilapia NILs (25) . The different mode of action of these two inhibitors might en hance the flexibility of the fish to respond to environmental chal lenges. Tilapia melanotropes are more sensitive to MCH than to thyrotropin-releasing hormone (TRH), a stimulator of a-MSH release (EC50, 200 nM) (23) . However, with respect to the effect on differential a-MSH release MCH resembles TRH, which also enhances the di/mono ratio of released a-MSH (25) .
Immunoneutralization of MCH in NILs in vitro showed that in tilapia endogenous MCH inhibits a-MSH release from the melanotropes and that this inhibitory effect persists in vitro as long as 18 h, because after washout of the MCH antiserum a-MSH release restored to the low control levels. The inhibitory effect of MCH on tilapia melanotropes is in line with observa tions in trout and eel, that immunoabsorbance of endogenously released MCH enhanced the ratio of released over stored amounts of a-MSH (9) . These findings indicate that under physiological conditions the effect of MCH on a-MSH is inhibitory.
High concentrations of MCH (10 /¿A/) and MCH(2-17) (10 and 35 yM) significantly increased a-MSH release. The physi ological importance of this stimulation of a-MSH release is as yet unclear. It is doubtful whether concentrations up to 10 yM MCH, which are very high compared with MCH plasma values of trout (10 to 300 pA/) (14) (15) (16) 21) , occur in the teleost pituitary. However, it cannot be excluded that at the MCH nerve terminals in the vicinity of the melanotropes MCH occasionally reach mi cromolar concentrations. We demonstrated that the stimulation of a-MSH release by MCH could not be attributed to the slight cross-reactivity of MCH with the antibody used in the a-MSH RIA. The occurrence of this cross-reactivity supports the notion that the tertiary structures of a-MSH and MCH are related (11) . Apparently, this structural similarity is lost when the N-terminal amino acid (Asp) of MCH is removed, because MCH(2-17) ap peared not to cross-react with the a-MSH antibody (this study) and MCH(2-17) exhibited almost no a-MSH-like activity on skin melanophores (11, 26) . The stimulatory effect of MCH on the a-MSH release most probably is transduced by a mechanism different from that of the skin melanophores, because the effect of MCH(2-17) on a-MSH release from tilapia NILs was similar to that of MCH. Possibly, two MCH receptor subtypes, an inhib itory and a stimulatory one, occur in the teleost pituitary. How ever, we cannot exclude that MCH, at a high concentration, binds to receptors for other a-MSH release stimulating agents, such as TRH or CRH (25, 31) , although no structural similarity with these peptides has been described. The finding that MCH interacts with the a-MSH cell not only has implications for our understanding of the roles of both cell types in background adaptation, but probably also for their func tions in the response to stressors. In tilapia, both cell types are responsive to acidification as a stressor ( 17, 24) , and in trout MCH secretion and biosynthesis are affected during injection and dis turbance stress (6, 15) .
